Ten63 Therapeutics

Series-A
ten63tx.com Biotech & Healthcare
Total Funding $15.9M
Latest Round $15.9M Series-A
Last Announced May 2, 2023
Investors 1 Backer
Decision Makers 5 Verified

About Ten63 Therapeutics

Ten63 Therapeutics builds BEYOND, the world's first Large Quantum Chemistry Model — pairing generative chemistry at scale with quantum-accurate simulation (Superlearning) to design therapeutics for previously undruggable and under-drugged targets.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website ten63tx.com
Domain Registered Date Dec 17, 2019

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $15,900,000 · Series-A

    fundraisingfox.com

  2. Milestone

    Website domain registered

    ten63tx.com

Investors & Backers

1
IndieBio

Funding History

2 Rounds
Series-A · May 2, 2023
Venture Round · Undisclosed
Undisclosed Source

Founders & Leadership

2

Marcel Frenkel

Founder

Work email & phone locked Unlock →

Mark Hallen

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts